Extract
Bioenvision to Restate Prior Period Financial Statements to Reflect Increase in Income Tax Benefit and Corresponding Decrease in Net Loss Available to Shareholders.
NEW YORK -- Restatements Will Cause Delay in Filing the Company's Quarterly Report on Form 10-QSB for the Quarter Ended March 31, 2005
Bioenvision (Nasdaq: BIVN) today announced that management and the audit committee of the Company have concluded that Bioenvisi...See the full content of this document
Sponsored links
